222 related articles for article (PubMed ID: 32885156)
1. Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma.
Souhami A; Sartoris R; Rautou PE; Cauchy F; Bouattour M; Durand F; Giannelli V; Gigante E; Castera L; Valla D; Soubrane O; Vilgrain V; Ronot M
JHEP Rep; 2020 Oct; 2(5):100147. PubMed ID: 32885156
[TBL] [Abstract][Full Text] [Related]
2. Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension.
Sartoris R; Rautou PE; Elkrief L; Pollorsi G; Durand F; Valla D; Spahr L; Terraz S; Soubrane O; Cauchy F; Vilgrain V; Ronot M
Radiology; 2018 Dec; 289(3):698-707. PubMed ID: 30179109
[TBL] [Abstract][Full Text] [Related]
3. CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma.
Romero-Cristóbal M; Clemente-Sánchez A; Ramón E; Téllez L; Canales E; Ortega-Lobete O; Velilla-Aparicio E; Catalina MV; Ibáñez-Samaniego L; Alonso S; Colón A; Matilla AM; Salcedo M; Albillos A; Bañares R; Rincón D
JHEP Rep; 2023 Mar; 5(3):100645. PubMed ID: 36691569
[TBL] [Abstract][Full Text] [Related]
4. Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT.
De Vos N; Sartoris R; Cauchy F; Rautou PE; Vilgrain V; Ronot M
Abdom Radiol (NY); 2020 Feb; 45(2):365-372. PubMed ID: 31797023
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data.
Hong WK; Kim MY; Baik SK; Shin SY; Kim JM; Kang YS; Lim YL; Kim YJ; Cho YZ; Hwang HW; Lee JH; Chae MH; Kim HA; Kang HW; Kwon SO
Clin Mol Hepatol; 2013 Dec; 19(4):370-5. PubMed ID: 24459641
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive tests for clinically significant portal hypertension after HCV cure.
Semmler G; Lens S; Meyer EL; Baiges A; Alvardo-Tapias E; Llop E; Tellez L; Schwabl P; Mauro E; Escudé L; Díez C; Ibañez-Samaniego L; Puente Á; Fortea JI; Abadía M; Zanetto A; Conthe A; Hernandez-Évole H; Luzko Scheid IS; Jia J; Yoshiji H; Francque SM; Tsochatzis EA; Russo FP; Crespo G; Forns X; Bañares R; Villanueva C; Hernández-Gea V; Reiberger T; Bosch J; García Pagán JC; Mandorfer M;
J Hepatol; 2022 Dec; 77(6):1573-1585. PubMed ID: 36063968
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of transient elastography in diagnosing clinically significant portal hypertension in patients with chronic liver disease: a systematic review and meta-analysis.
Kumar A; Maruyama H; Arora A; Sharma P; Anikhindi SA; Bansal N; Kumar M; Ranjan P; Sachdeva M; Khare S
J Med Ultrason (2001); 2022 Jul; 49(3):333-346. PubMed ID: 35876975
[TBL] [Abstract][Full Text] [Related]
8. Derivation and Validation of a Model to Predict Clinically Significant Portal Hypertension Using Transient Elastography and FIB-4.
Banini BA; Patel S; Yu JW; Kang L; Bailey C; Strife BJ; Siddiqui MS; Patel V; Matherly SC; Lee H; Lewis S; Cherian R; Stravitz RT; Luketic V; Sanyal AJ; Sterling RK
J Clin Gastroenterol; 2023 Feb; 57(2):189-197. PubMed ID: 34999644
[TBL] [Abstract][Full Text] [Related]
9. CT-based liver surface nodularity for the detection of clinically significant portal hypertension: defining measurement quality criteria.
Sartoris R; Lazareth M; Nivolli A; Dioguardi Burgio M; Vilgrain V; Ronot M
Abdom Radiol (NY); 2020 Sep; 45(9):2755-2763. PubMed ID: 32270261
[TBL] [Abstract][Full Text] [Related]
10. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.
Berzigotti A; Seijo S; Arena U; Abraldes JG; Vizzutti F; García-Pagán JC; Pinzani M; Bosch J
Gastroenterology; 2013 Jan; 144(1):102-111.e1. PubMed ID: 23058320
[TBL] [Abstract][Full Text] [Related]
11. Assessment of clinically significant portal hypertension by two-dimensional shear wave elastography.
Grgurevic I; Madir A; Trkulja V; Bozin T; Aralica G; Podrug K; Mikolaševic I; Tsochatzis E; O'Beirne J; Pinzani M
Eur J Clin Invest; 2022 Jun; 52(6):e13750. PubMed ID: 35040495
[TBL] [Abstract][Full Text] [Related]
12. Good performance of liver stiffness measurement in the prediction of postoperative hepatic decompensation in patients with cirrhosis complicated with hepatocellular carcinoma.
Procopet B; Fischer P; Horhat A; Mois E; Stefanescu H; Comsa M; Graur F; Bartos A; Lupsor-Platon M; Badea R; Grigorescu M; Tantau M; Sparchez Z; Al Hajjar N
Med Ultrason; 2018 Aug; 20(3):272-277. PubMed ID: 30167578
[TBL] [Abstract][Full Text] [Related]
13. High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic-associated fatty liver disease.
Odriozola A; Puente Á; Cuadrado A; Iruzubieta P; Arias-Loste MT; Redondo C; Rivas C; Fábrega E; Crespo J; Fortea JI
Liver Int; 2023 Jul; 43(7):1446-1457. PubMed ID: 36912787
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Liver and Spleen Stiffness with Acoustic Radiation Force Impulse Quantification Elastography for Diagnosing Clinically Significant Portal Hypertension.
Attia D; Schoenemeier B; Rodt T; Negm AA; Lenzen H; Lankisch TO; Manns M; Gebel M; Potthoff A
Ultraschall Med; 2015 Dec; 36(6):603-10. PubMed ID: 26565516
[TBL] [Abstract][Full Text] [Related]
15. Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography.
Podrug K; Trkulja V; Zelenika M; Bokun T; Madir A; Kanizaj TF; O'Beirne J; Grgurevic I
Dig Dis Sci; 2022 Jul; 67(7):3327-3332. PubMed ID: 34739624
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
Pons M; Augustin S; Scheiner B; Guillaume M; Rosselli M; Rodrigues SG; Stefanescu H; Ma MM; Mandorfer M; Mergeay-Fabre M; Procopet B; Schwabl P; Ferlitsch A; Semmler G; Berzigotti A; Tsochatzis E; Bureau C; Reiberger T; Bosch J; Abraldes JG; Genescà J
Am J Gastroenterol; 2021 Apr; 116(4):723-732. PubMed ID: 33982942
[TBL] [Abstract][Full Text] [Related]
17. Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study.
Augustin S; Millán L; González A; Martell M; Gelabert A; Segarra A; Serres X; Esteban R; Genescà J
J Hepatol; 2014 Mar; 60(3):561-9. PubMed ID: 24211744
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.
Simbrunner B; Marculescu R; Scheiner B; Schwabl P; Bucsics T; Stadlmann A; Bauer DJM; Paternostro R; Eigenbauer E; Pinter M; Stättermayer AF; Trauner M; Mandorfer M; Reiberger T
Liver Int; 2020 Jul; 40(7):1713-1724. PubMed ID: 32358998
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of liver and spleen stiffness measurement based on two-dimensional shear wave elastography for the portal vein pressure in patients with compensatory viral cirrhosis.
Wang P; Hu X; Xie F
PeerJ; 2023; 11():e15956. PubMed ID: 37727690
[TBL] [Abstract][Full Text] [Related]
20. Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension.
Semmler G; Hartl L; Mendoza YP; Simbrunner B; Jachs M; Balcar L; Schwarz M; Hofer BS; Fritz L; Schedlbauer A; Stopfer K; Neumayer D; Maurer J; Szymanski R; Meyer EL; Scheiner B; Quehenberger P; Trauner M; Aigner E; Berzigotti A; Reiberger T; Mandorfer M
Hepatology; 2024 Mar; ():. PubMed ID: 38447034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
